Humans pIKK-up NLRP3 to skip NEK7.
IKKβ
NEK7
NLRP3
TAK1
cell death
inflammasome
Journal
Trends in immunology
ISSN: 1471-4981
Titre abrégé: Trends Immunol
Pays: England
ID NLM: 100966032
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
07
10
2022
accepted:
14
10
2022
pubmed:
21
11
2022
medline:
29
11
2022
entrez:
20
11
2022
Statut:
ppublish
Résumé
NLRP3 inflammasome regulation is essential for controlling cell death and inflammation. Mechanistic studies in murine cells suggest a two-step model of priming and activation with an indispensable role for NEK7. However, in a recent article in Immunity, Schmacke et al. report that, in humans, transcription-independent NLRP3 activation occurs by circumventing NEK7 via IKKβ.
Identifiants
pubmed: 36404209
pii: S1471-4906(22)00228-9
doi: 10.1016/j.it.2022.10.007
pii:
doi:
Substances chimiques
NLR Family, Pyrin Domain-Containing 3 Protein
0
NIMA-Related Kinases
EC 2.7.11.1
Inflammasomes
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
NEK7 protein, human
EC 2.7.11.1
Nlrp3 protein, mouse
0
Nek7 protein, mouse
EC 2.7.11.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
947-949Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests T.-D.K. is a consultant for Pfizer.